New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research
Boston, MA -- (SBWIRE) -- 02/05/2014 -- Global Market Direct's pharmaceuticals report, "Metabolic Solutions Development Co. - Product Pipeline Review - 2013" provides data on the Metabolic Solutions Development Co.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Metabolic Solutions Development Co.'s corporate website, SEC filings, investor presentations and featured press releases, both from Metabolic Solutions Development Co. and industry-specific third party sources, put together by Global Markets Direct's team.
- Metabolic Solutions Development Co. - Brief Metabolic Solutions Development Co. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Metabolic Solutions Development Co. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Metabolic Solutions Development Co. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Metabolic Solutions Development Co.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
View Full Report Details and Table of Contents
Reasons to Get This Report
- Evaluate Metabolic Solutions Development Co.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Metabolic Solutions Development Co. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Metabolic Solutions Development Co.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Metabolic Solutions Development Co..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Metabolic Solutions Development Co. and identify potential opportunities in those areas.
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Plethora Solutions Holdings plc - Product Pipeline Review - 2013
- Metabolic Syndrome - Pipeline Review, H2 2013
- Inbiopro Solutions Pvt. Ltd. - Product Pipeline Review - 2013
- Fatty Liver Disease - Pipeline Review, H2 2013
- Metabolic Disorders - Pipeline Review, H1 2013
- Other Metabolic Disorders - Pipeline Review, H2 2013
- Polycystic Kidney Disease - Pipeline Review, H2 2013
- Fatty Liver Disease - Pipeline Review, H1 2013
- Inherited Metabolic Disorders - Pipeline Review, H2 2013
- Overactive Bladder - Pipeline Review, H2 2013